Mutual Advisors LLC Boosts Holdings in The Allstate Co. (NYSE:ALL)

Mutual Advisors LLC increased its holdings in The Allstate Co. (NYSE:ALLFree Report) by 24.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,331 shares of the insurance provider’s stock after purchasing an additional 465 shares during the period. Mutual Advisors LLC’s holdings in Allstate were worth $445,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. JPMorgan Chase & Co. grew its stake in shares of Allstate by 5.2% during the third quarter. JPMorgan Chase & Co. now owns 577,934 shares of the insurance provider’s stock valued at $109,605,000 after buying an additional 28,584 shares during the last quarter. Ameritas Advisory Services LLC increased its stake in Allstate by 117.3% in the 4th quarter. Ameritas Advisory Services LLC now owns 4,896 shares of the insurance provider’s stock worth $944,000 after purchasing an additional 2,643 shares during the period. Hennessy Advisors Inc. lifted its position in Allstate by 6.9% in the fourth quarter. Hennessy Advisors Inc. now owns 58,600 shares of the insurance provider’s stock valued at $11,297,000 after purchasing an additional 3,800 shares during the last quarter. Artemis Investment Management LLP boosted its stake in shares of Allstate by 33.3% during the fourth quarter. Artemis Investment Management LLP now owns 401,542 shares of the insurance provider’s stock valued at $77,413,000 after purchasing an additional 100,311 shares during the period. Finally, Eagle Asset Management Inc. grew its holdings in shares of Allstate by 38.0% in the third quarter. Eagle Asset Management Inc. now owns 10,497 shares of the insurance provider’s stock worth $2,067,000 after purchasing an additional 2,888 shares during the last quarter. Institutional investors own 76.47% of the company’s stock.

Allstate Stock Performance

Shares of ALL opened at $193.02 on Tuesday. The business’s 50 day moving average price is $194.70 and its 200-day moving average price is $187.66. The stock has a market cap of $51.11 billion, a P/E ratio of 12.50, a P/E/G ratio of 1.41 and a beta of 0.52. The Allstate Co. has a 52 week low of $153.42 and a 52 week high of $209.88. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43.

Allstate (NYSE:ALLGet Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating the consensus estimate of $2.20 by $1.71. The firm had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The company’s revenue was up 14.7% on a year-over-year basis. During the same period last year, the company earned $0.81 earnings per share. Equities research analysts anticipate that The Allstate Co. will post 16.83 earnings per share for the current fiscal year.

Allstate Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th were issued a $0.92 dividend. The ex-dividend date of this dividend was Friday, November 29th. This represents a $3.68 annualized dividend and a yield of 1.91%. Allstate’s dividend payout ratio (DPR) is presently 23.83%.

Analyst Upgrades and Downgrades

ALL has been the subject of several analyst reports. BMO Capital Markets increased their price target on shares of Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Evercore ISI upgraded shares of Allstate from an “in-line” rating to an “outperform” rating in a report on Wednesday, January 8th. The Goldman Sachs Group boosted their price target on Allstate from $209.00 to $230.00 and gave the company a “buy” rating in a report on Friday, November 15th. Piper Sandler increased their price objective on Allstate from $206.00 to $244.00 and gave the stock an “overweight” rating in a report on Tuesday, November 26th. Finally, UBS Group boosted their target price on Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, November 4th. One research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Allstate has a consensus rating of “Moderate Buy” and a consensus target price of $218.13.

Read Our Latest Stock Analysis on ALL

About Allstate

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Articles

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALLFree Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.